戻る Agenda
Enhancing Patient-Focused Outcome Assessment in Medical Product Development
Session Chair(s)
Elektra Papadopoulos, MD, MPH
Director, Patient Experience Data and Strategy
AbbVie, United States
This session will discuss the evolution of patient-focused outcome assessment and how current FDA efforts and resources support measuring what matters most to patients in medical product development. Join the Study Endpoints Community for a follow up Round Table discussion on Tuesday, June 25, 9:30-10:30AM in the DIA Community Zone 2, Sails Pavilion.
Learning Objective : Describe FDA's activities to promote patient voice in outcome measurement; Describe FDA resources to support the science of patient input in medical product development.
Speaker(s)
Update from CDRH
Michelle Tarver, MD, PHD
FDA, United States
Deputy Center Director for Transformation, CDRH
Panelist
Telba Irony, PHD, MS, MSC
Janssen R&D, United States
Senior Scientific Director, Quantitative Sciences
Industry Perspective
Robyn T. Carson, MPH
AbbVie, United States
Vice President, Patient-Centered Outcomes Research
Patient Perspective
Bray Patrick-Lake, MS
FDA, United States
Senior Digital Health Specialist, DDH, CDRH